Vimentin is a cytoskeletal protein expressed by mesenchymal cells, including endothelial and renal tubular cells. Antibodies to vimentin were described in 10%–53% of patients with Systemic Lupus ...

Hemoglobin-based blood substitutes are being developed as oxygen-carrying agents for the prevention of ischemic tissue damage and hypovolemic (low blood volume) shock.